The cost of caring for end-stage kidney disease patients: An analysis based on hospital financial transaction records

Journal of the American Society of Nephrology

Volumn 9, Issue 5, 1998, Pages 884-890

  Bruns, Frank J ^a   Seddon, Patricia ^a   Saul, Melissa ^a   Zeidel, Mark L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE COST; HEALTH CARE POLICY; HEMODIALYSIS; HOSPITAL COST; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; REIMBURSEMENT;

EID: 0031959988     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. U.S. Renal Data System: USRDS 1997 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, April 1997
2. Iglehart JK: The American health care system: The end stage renal disease program. N Engl J Med 328: 366-371, 1993
3. Levinsky NG: The organization of medical care: Lessons from the Medicare end stage renal disease program. N Engl J Med 329: 1395-1399, 1993
4. Friedman EA: End-stage renal disease therapy: An American success story. JAMA 275: 1118-1122, 1996
5. Held PJ, Carroll CE, Liska DW, Turenne MN, Port FK: Hemodialysis therapy in the United States: What is the dose and does it matter? Am J Kidney Dis 24: 974-980, 1994
6. Renal Physicians Association: ESRD in the Age of Managed Care: A Primer, Renal Physicians Association Education Foundation, Washington DC, 1996
7. Westman MA, George S, Scheel PJ Jr, McMurray SD, Pulliam J: Options for dialysis providers in a global capitated environment. Nephrology News and Issues 10: 26-32, 1996
8. Golper TA, Brier ME, Bunke ME: Risk factors for peritonitis in long-term peritoneal dialysis: The network 9 peritonitis and catheter survival studies. Am J Kidney Dis 28: 428-436, 1996
9. Lupo A, Tarchini R, Cancarini G: Long-term outcome in continuous ambulatory peritoneal dialysis: A 10-year survey by the Italian Cooperative Peritoneal Dialysis Study Group. Am J Kidney Dis 24: 826-837, 1994
10. Zimmerman SW, Ahrens E, Johnson CA: Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 18: 225-231, 1991
11. Strawderman RL, Levine G, Hirth RA, Port FK, Held PJ: Using USRDS-generated hospitalization tables to compare local dialysis patient hospitalization rates to national rates. Kidney Int 50: 571-578, 1996
12. Byrne C, Vernon P, Cohen JJ: Effect of age and diagnosis on survival of older patients beginning chronic dialysis. JAMA 271: 34-36, 1994
13. Consensus Development Conference Panel: Morbidity and mortality of renal dialysis: An NIH conference statement. Ann Intern Med 121: 62-70, 1995
14. Kopple JD, Hakim RM, Held PJ: Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients. Am J Kidney Dis 24: 968-973, 1994
15. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ration and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
16. McGinnis C, Day LM, Pristave R: What are the options for nephrologists under capitation? Nephrology News and Issues 10: 21-25, 1996
17. Friedman EA: The best and worst times for dialytic therapy are now [Editorial]. ASAIO J 40: 107-108, 1994
18. Lundin AP, Russell EP, Friedman EA: Documentation of the hemodialysis prescription: A current evaluation. Am J Kidney Dis 27: 759-761, 1996